Anny Nguyen, APNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: Beloit Health System, 1969 West Hart Rd, Beloit, WI 53511 Phone: 608-364-5689 Fax: 608-364-5452 |
Betsy Ruth Press, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1905 E Huebbe Pkwy, Beloit, WI 53511 Phone: 608-364-2200 |
Renatta Meyer, APNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1969 W Hart Rd, Beloit, WI 53511 Phone: 608-364-5011 |
Trisha L. Field, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 655 3rd St Ste 200, Beloit, WI 53511 Phone: 608-363-7421 Fax: 608-363-7426 |
Indira Bhagwandin, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1969 West Hart Rd, Beloit, WI 53511 Phone: 608-364-5689 Fax: 608-364-5452 |
News Archive
In the general population, African Americans die at earlier ages than whites, but among patients on dialysis, African Americans live longer than whites. A new study helps explain this paradox and could help prolong the lives of all patients on dialysis.
In situations of chronic food shortage, parents are inclined to give boys a preferential treatment. Anyway, the health of their daughters suffers more from food insecurity. This is shown by research fromp the Institute of Tropical Medicine in Ethiopia, appearing in the journal Pediatrics.
A team of researchers has elucidated individual profiles of allergy reactivity in patients that are not protected after treatment with immunotherapy. The aim is to improve medical treatment of people who are allergic to insect stings.
In a new study published in Cancer Letters, American University researchers show how, as body mass index increases, so does the growth and spread of the blood cancer multiple myeloma, which accounts for about 10 percent of all blood cancers in patients.
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.
› Verified 7 days ago